Akzo Nobel reconfirms listing of Organon BioSciences

Arnhem, the Netherlands, January 25, 2007 — Akzo Nobel has previously announced its intention to separate its Pharma business, preferably through a listing of approximately 20 to 30 percent of Organon BioSciences shares on Euronext in Amsterdam in early 2007.

Over the last few weeks, Akzo Nobel has received preliminary expressions of interest from a number of parties regarding an acquisition of Organon BioSciences.

Akzo Nobel has carefully reviewed these preliminary proposals from the perspective of long-term shareholder value creation. Taking into consideration the interests of all stakeholders, the company reconfirms that it remains committed to its preferred route of a separate listing of Organon BioSciences.

As a result, Akzo Nobel has decided not to divert any resources away from pursuing the listing of Organon BioSciences within the original timeline.

- - -